New drug HRS-2183 put to the test in healthy volunteers
NCT ID NCT07232758
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 19 times
Summary
This early-stage study is testing a new injectable drug called HRS-2183 in 42 healthy Chinese adults aged 18 to 45. The main goal is to check if the drug is safe and how the body processes it after one or more doses. Participants will be closely monitored for side effects. This study does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHINESE HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250100, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.